• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Selumetinib-[13C6]

General Information
Catalog: BLP-001400
Molecular Formula: C11[13C]6H15BrClFN4O3
Molecular Weight: 463.64
Chemical Structure
Selumetinib-[13C6]
Description Labelled Selumetinib. Selumetinib, also known as AZD6244, is an orally bioavailable small molecule with potential antineoplastic activity. Selumetinib inhibits mitogen-activated protein kinase kinases (MEK or MAPK/ERK kinases) 1 and 2, which may prevent the activation of MEK1/2-dependent effector proteins and transcription factors, and so may inhibit cellular proliferation in MEK-overexpressing tumor cells. MEK 1 and 2 are dual-specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various tumor cell types, and are drivers of diverse cellular activities, including cellular proliferation. Check for active clinical trials or closed clinical trials using this agent.
Related CAS 606143-52-6 (unlabelled)
Purity 98%; 99% atom 13C
Solubility Soluble in Dimethyl sulfoxide (200 mg/mL) or Ethanol (2.5 mg/mL)
Appearance White to Off-white solid

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket